Your Results

Here are clinical trials that currently enrolling participants.

woman
TRACTION-2 Clinical Trial of FSGS| Focal Segmental Glomerulosclerosis

The TRACTION-2 clinical research trial is evaluating an investigational product called GFB-887 for the potential treatment of focal segmental glomerulosclerosis (FSGS), treatment-resistant minimal change disease (TR-MCD), and diabetic nephropathy (DN). The purpose of the trial is to determine if GFB-887 is safe and may help people who have high levels of protein in their urine due to their kidney disease.

Visit Website
woman
NATRON Clinical Study | Hypereosinophilic syndrome (HES)

The NATRON clinical study is researching an investigational drug for hypereosinophilic syndrome (HES) to determine if it helps to control HES when added to standard of care medications.

Visit Website
woman
COVID-19 Clinical Trial Connect

Would you like to participate in a research study to help better understand or find a treatment or vaccine for COVID-19? There are numerous COVID-19 research studies being conducted through the United States to track people’s symptoms, learn more about our immune response to COVID-19 and investigate potential new treatments and vaccines. Whether you are healthy, have been exposed to COVID-19, are currently experiencing symptoms, have been diagnosed or have recovered, you may be eligible to take part in a local COVID-19 research study.

Visit Website
woman
AXLerate-OC | Now Enrolling

If you have ovarian cancer that returned after treatment, you might be uncertain about next steps. Joining a research study may be one option to consider. The AXLerate-OC study is testing an investigational* drug called batiraxcept. Researchers want to find out if this drug is safe and what effect it may have on ovarian cancer when combined with paclitaxel (a drug commonly used in ovarian cancer).

Visit Website
woman
dreaMM8 Driving Excellence in Approaches to Multiple Myeloma

Investigating the effectiveness and safety of belantamab mafodotin in combination with pomalidomide and dexamethasone compared to pomalidomide in combination with bortezomib and dexamethasone (bor/dex) for treatment of relapsed/refractory multiple myeloma

Visit Website

Join our Patient Community

Make a difference for yourself and others. Work with researchers and participants to gain access to the latest treatments. Sign up to be notified when there are studies for your condition or a loved one in your location. Participants of all backgrounds are needed as some conditions are more prevalent within certain populations. Whatever your age, gender, race or background – clinical trials need YOU!

    Submit